SJohnson et al_PARCA-R_Standardisation paper_Supp appendix_LCAH_R1.0.docx (155.27 kB)
1/0
2 files
Standardisation of the Parent Report of Children’s Abilities-Revised (PARCA-R): a norm-referenced assessment of cognitive and language development at 2 years of age
posted on 2019-06-06, 13:56authored bySamantha Johnson, Vasiliki Bountziouka, Peter Brocklehurst, Louise Linsell, Neil Marlow, Dieter Wolke, Brandley N. Manktelow
Background: To develop age- and sex-standardised scores for the Parent Report of
Children’s Abilities-Revised (PARCA-R) in order to assess children’s cognitive and language
development at 24 to 27 months of age.
Methods: Anonymised data from PARCA-R questionnaires completed by parents of 2 yearold children in three previous studies were obtained to form a standardisation sample
(n=6402) representative of the UK general population. Anonymised data were obtained from
three further studies to assess the external validity (n=709) and clinical validity (n=1456) of
the standardised scores. The L(lamda)M(mu)S(sigma) method was used to develop age- and
sex-specific standardised scores for three scales (non-verbal cognitive development; language
development; total Parent Report Composite (PRC)) for children in four 1-month age bands
spanning 23·5 to 27·5 months of age.
Findings: For all PARCA-R scales, mean (SD) standardised scores approximated 100 (15) in
both sexes and all age groups. These were independent of socio-economic status.
Standardised scores were close to 100 (15) in the external validation sample, demonstrating
the validity of the scores. Children born very preterm or with neonatal sepsis had,
respectively, standardised scores for the total PRC scale 0.47 SD and 0.73 SD lower on
average than the normative mean. These were equivalent to a standardised score of 93 (95%
Confidence interval (CI): 91 to 94) and 89 (95% CI: 88 to 91) respectively, thus
demonstrating clinical validity.
Interpretation: The PARCA-R provides a norm-referenced, standardised assessment of
cognitive and language development at 24-27 months of age. The questionnaire is available
non-commercially with translations currently available in 14 languages, thus providing
clinicians and researchers with a cost-effective tool for assessing development and
identifying children with delay.
Funding
This study was funded by Action Medical Research (Ref: GN2580)
History
Citation
Lancet Child and Adolescent Health, 2019, In Press
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences
The file associated with this record is under embargo until 6 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.